VASCO Expands Solutions for Healthcare with Epic Hyperspace Integration and FIPS 140-2 Level 2 Certification of DIGIPASS GO 7
Solutions Expand Interoperability and Satisfy Two-Factor Authentication Requirements for Electronic Prescription of Controlled Substances (EPCS)
OAKBROOK TERRACE, Ill., Oct. 21, 2015 /PRNewswire/ -- VASCO Data Security International, Inc. (NASDAQ: VDSI), a global leader in authentication, electronic signatures, and identity management, announced today two new solutions targeting the rapidly growing healthcare segment, DIGIPASS Authentication for Epic Hyperspace and DIGIPASS GO 7 hardware authenticator for healthcare.
DIGIPASS Authentication for Epic Hyperspace is a plug-in for IDENTIKEY Authentication Server and integrates in Epic Hyperspace, the leading software for electronic health records (EHR).
DIGIPASS Authentication for Epic Hyperspace is a client-side .NET module that adds support for two-factor authentication using a DIGIPASS Authenticator. It supports 1-step and 2-step challenge/response and response only authentication.
DIGIPASS GO 7 is a one-button hardware authentication device that has recently been validated as FIPS 140-2 Level 2 compliant by the federal National Institute of Standards and Technology (NIST). DIGIPASS GO 7 complies with all requirements that fall under the federal government mandate. It satisfies the requirements regarding strong, two-factor authentication of healthcare providers from the DEA's Rule for the Electronic Prescription of Controlled Substances (EPCS). DIGIPASS GO 7 is ideal for authentication and e-prescribing with Epic and many other leading EHR solutions
Both solutions deliver enhanced security through the support of dynamic one-time passwords (OTP) that provide a unique, non-reusable password for accessing applications, websites and networks. The use of OTPs helps protect against the use of stolen passwords by hackers and allows for the authentication of doctors and other healthcare providers for multiple uses including the electronic prescription of controlled substances in compliance with tighter regulations regarding meaningful use criteria and national laws.
"When dealing with highly sensitive information such as patient data and the prescription of controlled substances, proper IT security is top of mind for every healthcare professional, especially in light of recent breaches," stated Frederik Mennes, Senior Manager Market & Security Strategy for VASCO. "Support of Epic Hyperspace and achieving FIPS 140-2 certification emphasizes VASCO's commitment to exceeding the IT security needs of organizations in the healthcare segment."
The validation testing for DIGIPASS GO 7 was performed by InfoGard, the first and largest private IT security laboratory accredited by the United States National Institute of Standards and Technology. InfoGard is also accredited for certifications in the healthcare market as an approved certifying organization for the DEA EPCS Certification Program.
About VASCO
VASCO is a world leader in providing two-factor authentication and digital signature solutions to financial institutions. Many of the top 100 global banks rely on VASCO solutions to enhance security, protect mobile applications and meet regulatory requirements. VASCO also secures access to data and applications in enterprise environments, and provides tools for application developers to easily integrate security functions into their web-based and mobile applications. VASCO enables more than 10,000 customers in 100 countries to secure access, manage identities, verify transactions, and protect assets across financial, enterprise, E-commerce, government and healthcare markets. Learn more about VASCO at vasco.com and on Twitter, LinkedIn and Facebook.
For more information:
Corporate Communications
+1-847-370-1486 (US) or +32 2 609 97 00 (ROW)
[email protected]
SOURCE VASCO Data Security International, Inc.
Share this article